190 related articles for article (PubMed ID: 11128673)
1. Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis.
Sato S; Hanakawa H; Hasegawa M; Nagaoka T; Hamaguchi Y; Nishijima C; Komatsu K; Hirata A; Takehara K
J Rheumatol; 2000 Dec; 27(12):2838-42. PubMed ID: 11128673
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa M; Fujimoto M; Kikuchi K; Takehara K
J Rheumatol; 1997 Feb; 24(2):328-32. PubMed ID: 9034992
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1.
Giacomelli R; Cipriani P; Danese C; Pizzuto F; Lattanzio R; Parzanese I; Passacantando A; Perego MA; Tonietti G
J Rheumatol; 1996 Feb; 23(2):291-6. PubMed ID: 8882034
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
Tsuji-Yamada J; Nakazawa M; Minami M; Sasaki T
J Rheumatol; 2001 Jun; 28(6):1252-8. PubMed ID: 11409116
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
Jacob SE; Nassiri M; Kerdel FA; Vincek V
Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
[TBL] [Abstract][Full Text] [Related]
11. Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
[TBL] [Abstract][Full Text] [Related]
12. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
[TBL] [Abstract][Full Text] [Related]
14. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
15. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis.
Park SH; Min DJ; Cho ML; Kim WU; Youn J; Park W; Cho CS; Kim HY
Arthritis Rheum; 2001 Mar; 44(3):561-9. PubMed ID: 11263770
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
17. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
Hasegawa M; Sato S; Takehara K
Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-17 production in patients with systemic sclerosis.
Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract.
Kovacs E
Biomed Pharmacother; 2000 Jul; 54(6):305-10. PubMed ID: 10989963
[TBL] [Abstract][Full Text] [Related]
20. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis.
El-Mezayen RE; Matsumoto T
Clin Immunol; 2004 Apr; 111(1):61-8. PubMed ID: 15093553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
